Cargando…
Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
BACKGROUND: Bacterial vaginosis (BV) affects 30–50% of women at some time in their lives and is an embarrassing and distressing condition which can be associated with potentially serious comorbidities. Current antibiotic treatments such as metronidazole are effective but can result in side effects,...
Autores principales: | Armstrong-Buisseret, Lindsay, Brittain, Clare, David, Miruna, Dean, Gillian, Griffiths, Frances, Hepburn, Trish, Jackson, Louise, Kai, Joe, Montgomery, Alan, Roberts, Tracy, Thandi, Sukhwinder, Ross, Jonathan D. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880606/ https://www.ncbi.nlm.nih.gov/pubmed/31775859 http://dx.doi.org/10.1186/s13063-019-3731-7 |
Ejemplares similares
-
Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial
por: Ross, Jonathan D. C., et al.
Publicado: (2023) -
Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial
por: Anstey Watkins, Jocelyn, et al.
Publicado: (2019) -
In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide
por: O'Hanlon, Deirdre E, et al.
Publicado: (2011) -
Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review
por: Plummer, Erica L., et al.
Publicado: (2021) -
Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis
por: Ruiz-Perez, Daniel, et al.
Publicado: (2021)